Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21
Market Players, Key Developments, and Competitive Intelligence To learn more about this report, Key Developments On June 30, 2025, Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on peptide-based therapeutics, announced the nomination of PN-477, a triple agonist peptide targeting GLP-1, GIP, and GCG receptors, for obesity treatment
ventures such as Aledade, QGenda, Qventus, LeanTaaS, Iodine Software, and Clarify Health illustrate how workflow, capacity, scheduling, coding, and operational intelligence are becoming central to the Health Management Solutions stack
Apply a thin layer of IM FABULOUS COSMETICS GHK-Cu Organic Serum directly to the skin or within the micro-infusion device chamber
Contains 3,000 mg of L-Carnitine per serving
US$ 28.98
US$ 24.62
US$ 27.44
US$ 24.46
US$ 22.98
US$ 27.30
